4 completed. 4 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 3 | 2 | Completed 2 |
Follow Primary Hyperparathyroidism: new trials by email Literature Review of Primary Hyperparathyroidism trials Research Report on Primary Hyperparathyroidism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism eplerenone, amiloride, Placebo - Primary Hyperparathyroidism | Phase 2 / Phase 3 | Completed | Brigham and Women's Hospital | 69 | 2016-01-01 | 2023-05-03 |
| Effect of Vitamin D Treatment in Primary Hyperparathyroidism Cholecalciferol - Vitamin D Deficiency, Primary Hyperparathyroidism | Phase 2 / Phase 3 | Completed | University of Aarhus | 46 | 2008-05-01 | 2013-11-18 |
| Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT) Cinacalcet, Placebo - Primary Hyperparathyroidism | Phase 2 | Completed | Amgen | 10 | 2000-06-15 | 2018-12-14 |
| Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism Cinacalcet, Placebo - Primary Hyperparathyroidism | Phase 2 | Completed | Amgen | 48 | 1998-09-29 | 2018-12-13 |
Hyperparathyroidism, Primary (4) · Hypercalcemia (1) · Vitamin D Deficiency (1)
Endocrine System Diseases (4) · Hyperparathyroidism (4) · Parathyroid Diseases (4) · Avitaminosis (1) · Calcium Metabolism Disorders (1) · Deficiency Diseases (1) · Malnutrition (1) · Metabolic Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Water-Electrolyte Imbalance (1)
Cinacalcet (3) · Amiloride (1) · Cholecalciferol (1) · Eplerenone (1) · Vitamin D (1)
Amgen (2) · Brigham and Women's Hospital (1) · University of Aarhus (1)
Denmark (1) · United States (1)
Anand Vaidya, MD MMSc (1) · Lars Rejnmark, MD,PhD,DrMed (1) · Lars Rolighed, MD (1)